BuzzSparks.org

Inimex Pharmaceuticals


Innate Defense Regulators

Inimex Pharmaceuticals, Inc. is a clinical stage company focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body’s innate defenses without causing...

Homepage:
Total money raised: $26.5M

V5A 4T8 8540 Baxter Place

Burnaby, B.C.
Burnaby, B.C.
CAN

Phone: (604) 225-2251

Updated on Aug 24, 2009
Inimex Pharmaceuticals at CrunchBase
John R. North President & CEO
Martin (Marty) McConnell CFO
Oreola Donini Senior Director
Stephanie O'Brien Board Member
Pat Brady Director
Past

June, 2008

Inimex Pharmaceuticals raised $22M in a Series B round from Canadian Medical Discoveries Fund, Astellas Venture Management, Morningside Group, Roche Venture Fund, BC Advantage Funds, Discovery Capital, BDC Venture Capital, and GrowthWorks Capital

July, 2004

Inimex Pharmaceuticals raised $4.5M in a Series A round from BDC Venture Capital, Canadian Medical Discoveries Fund, and GrowthWorks Capital

Inimex Pharmaceuticals Announces $2 Million Second Closing of Series A    inimexpharma.com